These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7160521)

  • 1. Insulin antibodies in diabetic children treated with highly purified porcine NPH insulin. Comparison of results obtained by three methods of insulin antibody determination.
    Mäkelä AL; Akerblom HK; Mäkelä P
    Diabete Metab; 1982 Dec; 8(4):341-8. PubMed ID: 7160521
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin.
    Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA
    Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum levels of insulin-binding antibodies in diabetic children treated with monocomponent insulin].
    Symonides-Lawecka A; Ludwiczak H; Rogala H; Lawecki J; Czyzyk A
    Pol Tyg Lek; 1974 Apr; 29(16):641-3. PubMed ID: 4827230
    [No Abstract]   [Full Text] [Related]  

  • 5. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M; Tapanainen P; Veijola R
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.
    Robertson KJ; Schoenle E; Gucev Z; Mordhorst L; Gall MA; Ludvigsson J
    Diabet Med; 2007 Jan; 24(1):27-34. PubMed ID: 17227321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research on the dynamics of anti-insulin antibodies in children with diabetes mellitus].
    Puskas G; Lukács E; Indig B; Metz OB
    Pediatria (Bucur); 1973; 22(1):35-40. PubMed ID: 4733559
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological aspects of diabetes mellitus in children].
    Popa I; Deutsch G; Oţetea G; Schmidt-Georoceanu A; Man I; Bergel E
    Rev Pediatr Obstet Ginecol Pediatr; 1982; 31(1):63-72. PubMed ID: 6808644
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin antibodies and the actual insulin requirements in children and adolescents with primary diabetes].
    Karczewska K; Feluś E; Panek G; Otto-Buczkowska E; Dudziak Z
    Med Dosw Mikrobiol; 1974; 26(4):325-30. PubMed ID: 4475336
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus.
    Bolli GB
    J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():737-44. PubMed ID: 10626264
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin combinations: improving the treatment of juvenile diabetes].
    Gúrpide Arraya N; Durá Travé T; Moya Benavent M
    Rev Enferm; 1997; 20(227-8):17-20. PubMed ID: 9282075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibodies against therapeutic animal insulins and homologous proteins in the course of diabetes in children and adolescents].
    Karczewska K
    Med Dosw Mikrobiol; 1974; 26(4):317-24. PubMed ID: 4475335
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin--binding antibodies in Nigerian diabetic patients.
    Bella AF; Adetuyibi A
    West Afr J Med; 1990; 9(4):291-4. PubMed ID: 2083207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-insulin antibodies in children with diabetes mellitus].
    Puskás G; Lukács E; Indig B
    Pediatria (Bucur); 1970; 19(3):221-6. PubMed ID: 5453793
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin antibody formation in diabetic children (author's transl)].
    Stögmann W; Statz H
    Padiatr Padol; 1980; 15(4):385-92. PubMed ID: 7007991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus.
    Wutte A; Plank J; Bodenlenz M; Magnes C; Regittnig W; Sinner F; Rønn B; Zdravkovic M; Pieber TR
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):461-7. PubMed ID: 17647145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibodies to insulin in children with diabetes mellitus].
    Enikeev RG
    Vopr Okhr Materin Det; 1975 Feb; 20(2):45-7. PubMed ID: 1136302
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medium-term results of treatment with biosynthetic human insulin in diabetic children already in therapy with insulin of animal origin].
    Vanelli M; Bolondi O; Boselli E; Chiari G; Vittorangeli R; Rasori E; Nori G; Bernasconi S
    Minerva Pediatr; 1987 Aug; 39(15-16):669-74. PubMed ID: 3312993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.